When was Daye founded?

Daye was founded in 2018 and raised its 1st funding round within a year of its incorporation.

Where is Daye located?

Daye is headquartered in London, United Kingdom.

Which legal entities is Daye associated with?

Daye is associated with Anne's Day Ltd.

How many employees does Daye have?

As of Aug 31, 2026, the latest employee count at Daye is 117.

Is Daye a funded company?

Daye is a funded company, having raised a total of $19.2M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 07, 2018.

How much is Daye worth?

The latest valuation of Daye is $***** as of May 17, 2019.

When was the latest funding round of Daye?

Daye's latest funding was a $***** Series A round on Nov 21, 2025, with participation from 0 investor.

What is the annual revenue of Daye?

Annual revenue of Daye is between £1M and £10M as on Dec 31, 2023

Where does Daye rank among its competitors?

Daye ranks 1st amongst 40 active competitors, of which 5 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Xella Health, which secured $4.7M in Jun, 2026.

Who are the top competitors of Daye?

Daye's top competitors include Provista Diagnostics, Beikang Medical and Intignus Biotech. Among them, Xella Health secured the most recent funding round in June, 2026.

Daye - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Manufacturer of period care products and provider of health tests. Offerings include organic tampons, hemp pads, and diagnostic screening kits for vaginal health, hormonal balance, and fertility. Consultations with healthcare professionals are available to interpret diagnostic results and provide clinical guidance. The business supplies supplements for gut and vaginal microbiome support. All diagnostic testing is performed by accredited laboratories, and products are manufactured according to medical device standards.

Website: www.yourdaye.com/
Social
Email ID: *****@yourdaye.com

Key Metrics

Founded Year

2018

Location

London, United Kingdom

Stage

Series A

Total Funding

$19.2M in 4 rounds

Latest Funding Round

Series A, Nov 21, 2025, $*****

Post Money Valuation

$***** as on May 17, 2019

Investors

Index Ventures & 26 more

Ranked

1^st among 40 active competitors

Annual Revenue

£1M - £10M as on Dec 31, 2023

Employee Count

117 as on Aug 31, 2026

Similar Companies

Provista Diagnostics & 43 more

View Daye's full profile

Daye is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Anne's Day Ltd CIN: 11044785 , United Kingdom, Active	Nov 01, 2017	£1M - £10M (As on Dec 31, 2023)	8 (As on Dec 31, 2024)

Daye has raised a total funding of $19.2M over 4 rounds. Its first funding round was on Sep 07, 2018. Daye has 17 institutional investors and 10 angel investors.

Here is the list of recent funding rounds of Daye:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 21, 2025	5616682	Series A	5919741	2437210	1544126	6606760
Oct 26, 2022	5428503	Series A	4039457	5659398	5396424	MassMutual Ventures & 5 more
May 10, 2019	5606135	Series A	8169915	4052865	Khosla Ventures	Index Ventures & 6 more

Access funding benchmarks and valuations. Sign up today!

View details of Daye's funding rounds and investors

The founders of Daye is Valentina Milanova.

Here are the details of Daye's key team members:

Valentina Milanova: Founder & CEO of Daye. They serve on the board of 1 company.
Contact Info: 1 email address

Daye's Board of Directors

Daye's board has 2 active members. Valentina Milanova is part of team and Kristina Simmons is independent board member.

Here is the list of Daye's board of directors:

Name	Type	Representing	Status	Duration
Valentina Milanova	Team	-	Current	8y 11m
Kristina Simmons	Independent board member	-	Current	7y 5m
loggzio	Independent board member	-	Past	1y 6m
vusgurc	Independent board member	-	Past	5y 6m

View details of Daye's Founder profiles and Board Members

Daye's employee count trend

Daye has 117 employees as of Aug 26. Here is Daye's employee count trend over the years:

Uncover Daye's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Daye include Provista Diagnostics, Beikang Medical and Intignus Biotech. Here is the list of Top 10 competitors of Daye, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Daye 2018, London (United Kingdom), Series A	Manufacturer of period care products and provider of health tests	$19.2M	Salica Investments, Hummingbird Ventures ... & 25 others	56/100
2nd	Provista Diagnostics 2007, New York City (United States), Acquired	Molecular oncology diagnostics company	$41.8M	Direct Strategy	44/100
3rd	Beikang Medical 2010, Suzhou (China), Public	Developer of NGS-based diagnostic solutions for neonatal	$36.5M	Broad Vision Funds, Yixiang Capital & 3 others	43/100
4th	Intignus Biotech 2018, Pune (India), Seed	Manufacturer of early diagnosis device for pregnancy-related disorders	$289K	IIT Kanpur, Venture Center & 7 others	39/100
5th	bioLOCKEY Healthworks 2023, Bengaluru (India), Seed	Developer of point-of-care diagnostics and novel biologics by Nanobody discovery platform	$478K	Pfizer, Pfizerindovation & 7 others	37/100
6th	Heranova Lifesciences 2022, Burlington (United States), Seed	Developing diagnostics and treatments for womens health	$13.5M	Pivotal bioVenture Partners China	36/100
7th	Xella Health 2000, Belgium, Seed	Provider of precision health testing and personalized clinical care services	$4.7M	Ulu Ventures, Precursor Ventures & 2 others	32/100
8th	Latde Diagnostics 2021, Amherst (United States), Funding Raised	Developer of diagnostic test for urinary tract infections	-	University Lab Partners, HHS	30/100
9th	Sabera Healthcare 2021, Mangaluru (India), Unfunded	Developer of point-of-care diagnostic devices focused on women's health	-	-	28/100
10th	Koroglu Medical 2008, Izmir (Turkey), Unfunded	In vitro diagnostic assays and devices	-	-	27/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Daye's competitors? Click here to see the top ones

Founders (largest shareholder) own 51.40%, Funds own 47.30%, Enterprises own 0.30% and Angels own 0.70%. The net worth of Daye's founders is INR 6.34M as of May 17, 2019.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	51.40%	6.34M	6948391	7071405	9146720	6780831
Valentina Milanova	8386539	6060026	9930777	2841657	7001973	4792518
Fund	47.30%	5.84M	7177593	6306665	5630124	2413408
Khosla Ventures	3312160	2247596	2521354	2566869	3107899	8170213
Index Ventures	8576733	6887469	5537684	6527951	8341041	5565835
Kindred Capital	1401374	5469748	9176929	8738216	4570048	6254271
Enterprise	0.30%	31.8K	0	0	0	0
Angel	0.70%	73.9K	0	0	0	0
Total	99.70%	1.23Cr	1646211	3060650	8165560	4378092